Praxis Precision Medicines, Inc.
PRAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.17 | 0.02 | -0.03 | 0.12 |
| FCF Yield | -9.56% | -75.68% | -169.07% | -15.02% |
| EV / EBITDA | -5.83 | -0.54 | -0.25 | -4.24 |
| Quality | ||||
| ROIC | -44.80% | -172.35% | -265.50% | -65.31% |
| Gross Margin | 95.81% | 100.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.72 | 0.90 | 0.86 | 0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -18.50% | 40.06% | -47.68% | -138.70% |
| Safety | ||||
| Net Debt / EBITDA | 1.07 | 0.63 | 0.27 | 0.81 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -12,772.96 | 0.00 | -4,573.25 | -2,468.44 |